Jack Allen
Stock Analyst at Baird
(0)
# 4888
Out of 5,344 analysts
50
Total ratings
31.43%
Success rate
-26.03%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
FATE Fate Therapeutics | Maintains: Neutral | 5 4 | 1.17 | 241.88% | 2 | May 14, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Outperform | 12 9 | 1.05 | 757.14% | 3 | May 14, 2025 | |
CARM CARISMA Therapeutics | Downgrades: Neutral | 10 1 | 0.19 | 426.32% | 3 | Dec 12, 2024 | |
INKT MiNK Therapeutics | Maintains: Outperform | 80 40 | 7.14 | 460.22% | 2 | Nov 15, 2024 | |
VOR Vor Biopharma | Maintains: Outperform | 22 14 | 0.18 | 7677.78% | 3 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 77 106 | 63.96 | 65.73% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 18 | 9.19 | 95.87% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 180 180 | 21.16 | 750.66% | 9 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 120 | 4.99 | 2304.81% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 2.25 | 255.56% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 52 | 36.89 | 40.96% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 84 | 31.14 | 169.75% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 200 25 | n/a | n/a | 3 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 8 | 2.75 | 190.91% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 21 6 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 0.7 | 614.29% | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | n/a | n/a | 1 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 9 | 2.91 | 209.28% | 1 | Oct 7, 2021 |